Histology and cytology products play a crucial role in the diagnosis of various chronic diseases such as cancer. Histology utilizes microscopes to examine tissue or cell samples to diagnose diseases. Cytology involves examination of cell samples from bodily fluids or tissues. The increasing prevalence of chronic diseases such as cancer has accelerated the demand for histology and cytology procedures globally. Histology is widely used in disease diagnosis, drug discovery and clinical research applications.
The growing use of histology across various industries is expected to fuel market growth over the forecast period. The global histology and cytology market is estimated to be valued at US$ 20,882.22 Mn in 2023 and is expected to exhibit a CAGR of 13% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The growing prevalence of chronic diseases is one of the major trends spurring growth of the histology and cytology market. According to the World Health Organization (WHO), chronic diseases kill 41 million people each year, equivalent to 71% of all deaths globally. Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020 or nearly one in six deaths. The increasing cancer burden globally is driving significant demand for histology and cytology procedures to diagnose and monitor the progression of the disease. Furthermore, technological advancements in digital pathology and artificial intelligence are enabling faster and more accurate disease diagnosis using virtual slides. AI-powered digital pathology solutions are expected to significantly reduce diagnostic errors and improve patient outcomes over the coming years, thereby propelling the histology and cytology market growth.
Segment Analysis
Histopathology is currently the dominating sub segment in the histology and cytology market. Histopathology involves the microscopic examination of tissue samples to aid in disease diagnosis. It helps to identify cellular abnormalities, infectious agents, inflammatory changes or presence of cancerous tissue. The dominant share of histopathology is attributed to its better acceptance among pathologists and wider usage for disease diagnosis compared to other procedures.
Key Takeaways
The Global Histology And Cytology Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. Regional analysis- North America currently dominates the global market and is expected to maintain its lead through 2030. This is attributed to high healthcare expenditure, presence of advanced medical facilities and increasing cases of cancer in the region.
Key players related content comprises- Key players operating in the histology and cytology market are Abbott, Hologic Inc., Becton, Dickinson and Company, Southwest Precision Instruments, LLC, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Thermo Fisher Scientific Inc., Danaher, Life Technologies Corporation, Merck KGaA, Koninklijke Philips N.V., Perkin Elmer, and Trivitron Healthcare.
Explorer more information on this topic, Please visit-
